Business News • PR NewsWire • Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer

GOTHENBURG, Sweden, Oct. 18, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the successful completion of Japan's Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the start of...

View More : https://www.prnewswire.com:443/news-releases/isofol-receives-positive-feedback-from-pmda-in-japan-expanding-ongoing-glob...

Releted News by prnewswire

The Volvo Group Creates New Business Area for Autonomous Transport Solutions

„MEDIA ALERT: Niederländische Bauerngruppe ist kein Mitglied der Vereinigungskirche"

Korea's LG U+ Selects Ericsson as a 5G RAN and 5G Core Vendor

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer

Usan el activo digital TDN para adquirir UD$25 millones de grafito

Getinge Q3 2019 Result: Continued Growth and Improved Margins